Previous 10 | Next 10 |
Most people want to be financially secure in retirement. To achieve that goal, many shrewdly turn to the stock market. Investing in stocks allows your money to grow substantially more than, say, in a traditional savings account. Of course, the stock market also comes with risks, but picking...
Halvorsen's 13F portfolio value decreased marginally from $33.58B to $32.98B this quarter. The number of positions decreased from 94 to 88. Viking Global added FIGS Inc. & JD.com and increased Amazon.com & General Electric during the quarter. The top three positions are Am...
Guardant Health, Inc. (Nasdaq: GH), along with leading academic institutions and pharmaceutical companies, share data highlighting molecular targets of importance, treatment resistance patterns, and advantages of using the Guardant360 ® liquid biopsy test to help improve the manage...
GuardantINFORM™ clinical-genomic liquid biopsy dataset underscores need to improve HER-2 directed treatment in metastatic colorectal cancer Guardant Health, Inc. (Nasdaq: GH), along with leading academic institutions and pharmaceutical companies, share data highlighti...
REDWOOD CITY, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) along with leading academic institutions and pharmaceutical companies will present data demonstrating the advantages of using the Guardant360 ® liquid biopsy test for clinical decision-makin...
The precipitous cost decline of next-generation DNA sequencing has supercharged our understanding of tumor biology. The strange biology that makes it dangerous also gives scientists the opportunity to detect cancer earlier. The exponential cost declines associated with NGS, AI, an...
Philippe Laffont’s 13F portfolio value increased from $18.24B to $25.52B this quarter. Coatue Management increased Amazon.com, Moderna, Twilio, and Peloton Interactive while decreasing XPeng and dropping Farfetch Limited. The largest three positions are DoorDash, Amazon.com...
REDWOOD CITY, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating virtually in the upcoming Morgan Stanley Global Healthcare Conference. Guardant Health’s manageme...
According to a recent report, the global Precision Medicine Market is set to grow beyond $112 billion by 2027. Guardant’s Q2 revenues grew 39% over the year to $92.1 million, ahead of the Street’s forecast by 8.8%. By segment, revenues from Precision oncology grew 42...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations Summit. Guardant Health’s management is scheduled to participate in a fireside chat on Tuesday,...
News, Short Squeeze, Breakout and More Instantly...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and Clinical Genetics Panel of the U.S. Food and Drug Administration Medical Devices Advisory Committee is scheduled to review the premarket approval (PMA) application for the company’s ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the first quarter 2024 after market close on Thursday, May 9, 2024. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / ...
New research demonstrates value of epigenomic analysis and methylation sequencing with Guardant liquid biopsy portfolio across continuum of cancer care New data show strong performance of Guardant Reveal™ in detection and quantification of residual disease in early-stage breast can...